Brief: Senzime Gets Additional FDA Class II 510(K) Clearance For Tetragraph System
BRIEF-Senzime Gets Additional FDA Class II 510(K) Clearance For Tetragraph System May 27 (Reuters) - Senzime AB (publ) SEZI.ST:
RECEIVES ADDITIONAL FDA CLASS II 510(K) CLEARANCE FOR TETRAGRAPH SYSTEM
Source text: ID:nMFN8mZwMZ
Further company coverage: SEZI.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com;))
Recent news on Senzime AB (publ)
See all newsBrief: Senzime Q3 Sales Up At SEK 30.1 Million
Sweden's Senzime Q3 sales rise on strong sensor demand
Brief: Senzime Reaffirms Target Of Positive Cash Flow In Q4 2026
Brief: Senzime Announces New Non-Dilutive Credit Facility Of SEK 35 Mln
Brief: Senzime Wins Additional Major US Hospital Network Contract